BioDelivery Sciences Surging On Phase 3 Results Of BEMA

July 7, 2014 3:31 PM

9 0

BioDelivery Sciences Surging On Phase 3 Results Of BEMA

BioDelivery Sciences is surging today on news of positive phase 3 results of its drug BEMA buprenorphine

BioDelivery Sciences International, Inc. (BDSI) is up over 16% in trading today on news of positive phase 3 results of its BEMA buprenorphine tests on patients who have previously used opioids. With continued phase 3 success, the company will proceed to apply for its new drug application (NDA) with ...

Read more

To category page

Loading...